S1PR3 and Stroke: Therefore, the risk of adverse events related to vasoconstriction (hypertension, headache, and stroke) which may be associated with S1PR3 was predicted to be low (Willis and Cohen, 2013; Camm et al., 2014; Stepanovska et al., 2020).